InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Swayze Eric, VP Exécutif. Insider active across 1 company, notably Ionis Pharmaceuticals INC. Aggregated, 30 reports have been logged. Split: 0 buy · 10 sells. Total volume traded: €2.2m. History available since 18 January 2022. The latest transaction was disclosed on 27 February 2026 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Swayze Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
10,602 sharesCommon StockSEC:0000874015-26-000211:0
256 shares@ US$48.86650.2% of flowCommon StockSEC:0000874015-26-000125:0
9,435 shares@ US$81.559215.1% of flowCommon StockSEC:0000874015-26-000111:0
11,991 shares0Common StockSEC:0000874015-26-000102:0
21,366 shares0Common StockSEC:0000874015-26-000072:0
5,125 shares@ US$60.895.3% of flowCommon StockSEC:0000874015-26-000026:0
125 shares0Common StockSEC:0000874015-25-000262:0
6,849 shares@ US$69.0212.0% of flowCommon StockSEC:0000874015-25-000254:0
14,142 shares@ US$53.770.0050% mcap48.8% of flowCommon StockSEC:0000874015-25-000245:0
10,000 shares@ US$49.2214.2% of flowCommon StockSEC:0000874015-25-000224:0
415 shares@ US$28.21150.4% of flowCommon StockSEC:0000874015-25-000103:0
3,714 shares0Common StockSEC:0000874015-25-000081:0
19,111 shares0Common StockSEC:0000874015-25-000065:0
1,194 shares@ US$37.9211.3% of flowCommon StockSEC:0000874015-24-000241:0
125 shares0Common StockSEC:0000874015-24-000229:0
1,940 shares@ US$49.56132.8% of flowCommon StockSEC:0000874015-24-000196:0
11 shares@ US$38.6410.0% of flowCommon StockSEC:0000874015-24-000221:0
605 shares@ US$34.4250.6% of flowCommon StockSEC:0000874015-24-000126:0
10,773 shares@ US$52.0016.2% of flowCommon StockSEC:0000874015-24-000110:0
17,069 shares0Common StockSEC:0000874015-24-000078:0
27,100 shares@ US$47.3436.1% of flowCommon StockSEC:0000874015-24-000006:0
125 shares0Common StockSEC:0000874015-23-000203:0
575 shares@ US$30.5150.5% of flowCommon StockSEC:0000874015-23-000115:0
3,715 shares0Common StockSEC:0000874015-23-000096:0
15,780 shares0Common StockSEC:0000874015-23-000069:0
25 of 30 declarations
About Swayze Eric
Swayze Eric is VP Exécutif at Ionis Pharmaceuticals INC, where he is also EVP Research. He has made 30 filings in total, and across the recent sample of 30 filings, reported sales amount to EUR 2,158,452 with no reported purchases, between 2022-01-20 and 2026-06-26. The most frequent transaction nature is Levée d'options.
